Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of taurine ursodeoxycholic acid capsules for post-cholecystectomy dyspepsia
ChiCTR2300069942Phase 4Not yet recruiting
- Sponsor
- Hunan Provincial People's Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tauroursodeoxycholic acid in dyspepsia and postcholecystectomy syndrome (PCS), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Change of dyspepsia symptom score from baseline, Change in quality of life score from baseline and 1 more. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
dyspepsiapostcholecystectomy syndrome (PCS)
Beyond the preview
Go deeper on ChiCTR2300069942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069942.